These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1126 related articles for article (PubMed ID: 17331788)
21. Apoptosis and the conformational change of Bax induced by proteasomal inhibition of PC12 cells are inhibited by bcl-xL and bcl-2. Lang-Rollin I; Maniati M; Jabado O; Vekrellis K; Papantonis S; Rideout HJ; Stefanis L Apoptosis; 2005 Aug; 10(4):809-20. PubMed ID: 16133871 [TBL] [Abstract][Full Text] [Related]
22. Toxoplasma gondii infection confers resistance against BimS-induced apoptosis by preventing the activation and mitochondrial targeting of pro-apoptotic Bax. Hippe D; Weber A; Zhou L; Chang DC; Häcker G; Lüder CG J Cell Sci; 2009 Oct; 122(Pt 19):3511-21. PubMed ID: 19737817 [TBL] [Abstract][Full Text] [Related]
23. Myc potentiates apoptosis by stimulating Bax activity at the mitochondria. Soucie EL; Annis MG; Sedivy J; Filmus J; Leber B; Andrews DW; Penn LZ Mol Cell Biol; 2001 Jul; 21(14):4725-36. PubMed ID: 11416148 [TBL] [Abstract][Full Text] [Related]
24. Induction of apoptosis in renal tubular cells by histone deacetylase inhibitors, a family of anticancer agents. Dong G; Wang L; Wang CY; Yang T; Kumar MV; Dong Z J Pharmacol Exp Ther; 2008 Jun; 325(3):978-84. PubMed ID: 18310471 [TBL] [Abstract][Full Text] [Related]
25. MEK1/2 inhibitors potentiate UCN-01 lethality in human multiple myeloma cells through a Bim-dependent mechanism. Pei XY; Dai Y; Tenorio S; Lu J; Harada H; Dent P; Grant S Blood; 2007 Sep; 110(6):2092-101. PubMed ID: 17540843 [TBL] [Abstract][Full Text] [Related]
26. Functional and biological analysis of Bcl-xL expression in human osteosarcoma. Wang ZX; Yang JS; Pan X; Wang JR; Li J; Yin YM; De W Bone; 2010 Aug; 47(2):445-54. PubMed ID: 20580954 [TBL] [Abstract][Full Text] [Related]
27. Apoptosis induced by histone deacetylase inhibitors in leukemic cells is mediated by Bim and Noxa. Inoue S; Riley J; Gant TW; Dyer MJ; Cohen GM Leukemia; 2007 Aug; 21(8):1773-82. PubMed ID: 17525724 [TBL] [Abstract][Full Text] [Related]
28. The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim. Nikrad M; Johnson T; Puthalalath H; Coultas L; Adams J; Kraft AS Mol Cancer Ther; 2005 Mar; 4(3):443-9. PubMed ID: 15767553 [TBL] [Abstract][Full Text] [Related]
30. TGFbeta-mediated apoptosis of Burkitt's lymphoma BL41 cells is associated with the relocation of mitochondrial BimEL. Clybouw C; Mchichi BE; Hadji A; Portier A; Auffredou MT; Arnoult D; Leca G; Vazquez A Oncogene; 2008 May; 27(24):3446-56. PubMed ID: 18193085 [TBL] [Abstract][Full Text] [Related]
31. Promise of combining a Bcl-2 family inhibitor with bortezomib or SAHA for adult T-cell leukemia/lymphoma. Kunami N; Katsuya H; Nogami R; Ishitsuka K; Tamura K Anticancer Res; 2014 Oct; 34(10):5287-94. PubMed ID: 25275021 [TBL] [Abstract][Full Text] [Related]
32. The histone deacetylase inhibitor suberoylanilide hydroxamic acid down-regulates expression levels of Bcr-abl, c-Myc and HDAC3 in chronic myeloid leukemia cell lines. Xu Y; Voelter-Mahlknecht S; Mahlknecht U Int J Mol Med; 2005 Jan; 15(1):169-72. PubMed ID: 15583844 [TBL] [Abstract][Full Text] [Related]
33. Evidence for involvement of BH3-only proapoptotic members in adenovirus-induced apoptosis. Subramanian T; Vijayalingam S; Lomonosova E; Zhao LJ; Chinnadurai G J Virol; 2007 Oct; 81(19):10486-95. PubMed ID: 17652400 [TBL] [Abstract][Full Text] [Related]
34. Modulation of Bcl-2-related protein expression in pancreatic beta cells by pro-inflammatory cytokines and its dependence on the antioxidative defense status. Mehmeti I; Lenzen S; Lortz S Mol Cell Endocrinol; 2011 Jan; 332(1-2):88-96. PubMed ID: 20933054 [TBL] [Abstract][Full Text] [Related]
35. Bcl-xS and Bax induce different apoptotic pathways in PC12 cells. Lindenboim L; Yuan J; Stein R Oncogene; 2000 Mar; 19(14):1783-93. PubMed ID: 10777212 [TBL] [Abstract][Full Text] [Related]
36. Activation of multidomain and BH3-only pro-apoptotic Bcl-2 family members in p53-defective cells. Paquet C; Schmitt E; Beauchemin M; Bertrand R Apoptosis; 2004 Nov; 9(6):815-31. PubMed ID: 15505424 [TBL] [Abstract][Full Text] [Related]
37. Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice. Shankar S; Davis R; Singh KP; Kurzrock R; Ross DD; Srivastava RK Mol Cancer Ther; 2009 Jun; 8(6):1596-605. PubMed ID: 19509267 [TBL] [Abstract][Full Text] [Related]
38. The Mutant KRAS Gene Up-regulates BCL-XL Protein via STAT3 to Confer Apoptosis Resistance That Is Reversed by BIM Protein Induction and BCL-XL Antagonism. Zaanan A; Okamoto K; Kawakami H; Khazaie K; Huang S; Sinicrope FA J Biol Chem; 2015 Sep; 290(39):23838-49. PubMed ID: 26245900 [TBL] [Abstract][Full Text] [Related]
39. 2-deoxyglucose-induced toxicity is regulated by Bcl-2 family members and is enhanced by antagonizing Bcl-2 in lymphoma cell lines. Zagorodna O; Martin SM; Rutkowski DT; Kuwana T; Spitz DR; Knudson CM Oncogene; 2012 May; 31(22):2738-49. PubMed ID: 21986940 [TBL] [Abstract][Full Text] [Related]
40. Bim and Mcl-1 exert key roles in regulating JAK2V617F cell survival. Rubert J; Qian Z; Andraos R; Guthy DA; Radimerski T BMC Cancer; 2011 Jan; 11():24. PubMed ID: 21247487 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]